Evolut R Implantation to Treat Severe Pure Aortic Regurgitation in a Patient With Mitral Bioprosthesis.

@article{Bruschi2016EvolutRI,
  title={Evolut R Implantation to Treat Severe Pure Aortic Regurgitation in a Patient With Mitral Bioprosthesis.},
  author={Giuseppe Bruschi and Paola Colombo and Stefano Nava and Francesco Musca and Bruno Merlanti and Oriana Belli and Francesco S Soriano and Luca Botta and Danile De Caria and Cristina Giannattasio and Claudio Francesco Russo},
  journal={The Annals of thoracic surgery},
  year={2016},
  volume={102 6},
  pages={e521-e524}
}
Transcatheter aortic valves have been designed to treat high-risk surgical candidates affected by severe aortic stenosis, but little is known about the use of transcatheter valves in patients with severe pure aortic regurgitation. We describe the implantation of Medtronic CoreValve Evolut R (Medtronic, Minneapolis, MN) to treat an 82-year-old patient… CONTINUE READING